Daptomycin
- Product NDC
- 63323-585
- 11-digit product format
- 633230585
- Labeler code
- 63323
- Product ID
- 63323-585_8b136aa7-1ef2-3556-e053-2a95a90a617f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Daptomycin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- NDA209949
- Marketing category
- NDA
- Marketing start
- 2019-06-01
- Marketing end
- 0000-00-00
- Substance
- DAPTOMYCIN
- Active strength
- 350 mg/7mL
- Pharmacologic classes
- Lipopeptide Antibacterial [EPC],Lipopeptides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-585-15 | 63323058515 | 1 VIAL in 1 CARTON (63323-585-15) > 7 mL in 1 VIAL | 1 vial | 2019-06-01 | 0000-00-00 | No | No | Current |